“Ambrx Holders Who Bought for Pennies See 6,700% Gain on J&J Bid”

“Longtime believers in Ambrx Biopharma Inc. are being rewarded with juicy returns as Johnson & Johnson’s buyout offer values the biotech stock at more than 6,700% of its all-time low.

Johnson & Johnson agreed to acquire Ambrx for $28 per share in cash, an approximately 105% premium to its closing price prior to Monday’s announcement, valuing the drug developer at $2 billion. Ambrx is now trading in stark contrast to December 2022, when shares closed at a rock-bottom price of 41c and the company was at risk of being delisted…”

https://finance.yahoo.com/news/ambrx-holders-bought-pennies-see-120000437.html

trying to catch these types of deals is not a good idea in my opinion. Most of the time when companies are bought out they exchange the old stock for a new one. Long story short they screw the long term holders. I’ve been in the stock market for a while now and this is the first time i seen a favorable buyout like this.

Also the big rally is over. It’s to late to try to jump on board. Even if the stock 5x its not 6,700%.